Blueshift Asset Management LLC Has $1.83 Million Stock Holdings in Trupanion, Inc. $TRUP

Blueshift Asset Management LLC decreased its position in Trupanion, Inc. (NASDAQ:TRUP) by 12.5% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 33,039 shares of the financial services provider’s stock after selling 4,717 shares during the period. Trupanion comprises 0.6% of Blueshift Asset Management LLC’s portfolio, making the stock its 27th biggest position. Blueshift Asset Management LLC owned about 0.08% of Trupanion worth $1,829,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in TRUP. Wellington Management Group LLP boosted its stake in shares of Trupanion by 13.2% during the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider’s stock worth $92,848,000 after buying an additional 290,788 shares during the last quarter. Geode Capital Management LLC raised its holdings in Trupanion by 7.0% during the second quarter. Geode Capital Management LLC now owns 860,988 shares of the financial services provider’s stock worth $47,662,000 after acquiring an additional 56,671 shares in the last quarter. Hosking Partners LLP boosted its position in Trupanion by 86.9% during the first quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider’s stock valued at $14,821,000 after purchasing an additional 184,936 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its stake in Trupanion by 2,029.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 303,550 shares of the financial services provider’s stock valued at $11,313,000 after purchasing an additional 289,292 shares in the last quarter. Finally, Millennium Management LLC grew its stake in Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after purchasing an additional 113,490 shares in the last quarter.

Trupanion Price Performance

Trupanion stock opened at $34.03 on Tuesday. Trupanion, Inc. has a 12 month low of $31.00 and a 12 month high of $57.88. The stock’s 50 day moving average is $40.53 and its 200-day moving average is $45.89. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.47 billion, a price-to-earnings ratio of 130.89 and a beta of 1.82.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm had revenue of $366.92 million for the quarter, compared to analyst estimates of $361.58 million. During the same period in the previous year, the business posted $0.03 earnings per share. The business’s revenue for the quarter was up 12.0% on a year-over-year basis. Trupanion has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Stifel Nicolaus cut their price objective on Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a report on Tuesday, November 18th. Piper Sandler upped their price target on shares of Trupanion from $62.00 to $67.00 and gave the stock an “overweight” rating in a research report on Friday, August 8th. Cantor Fitzgerald raised shares of Trupanion to a “hold” rating in a research report on Wednesday, August 13th. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Tuesday, November 25th. Finally, Wall Street Zen upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $54.00.

Insider Buying and Selling at Trupanion

In related news, CEO Margaret Tooth sold 9,803 shares of the company’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $35.31, for a total value of $346,143.93. Following the transaction, the chief executive officer directly owned 151,899 shares in the company, valued at approximately $5,363,553.69. This represents a 6.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO John R. Gallagher sold 6,383 shares of Trupanion stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $34.82, for a total transaction of $222,256.06. Following the completion of the sale, the chief operating officer owned 32,721 shares of the company’s stock, valued at $1,139,345.22. This trade represents a 16.32% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 90,233 shares of company stock worth $3,788,812. Insiders own 5.42% of the company’s stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.